Ironwood Pharmaceuticals, Inc. Class A Common Stock (IRWD)
NASDAQ
Closed
Oct 8, 2026
Day's Range
3.6752 wk Range
1.41Overview - IRWD - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
917.56M
P/E (Trailing)
‪4.77‬
P/E (Forward)
‪2.42‬
PEG Ratio
‪0.04‬
Price / Sales (TTM)
‪1.54‬
Price / Book
‪-3.81‬
EV / EBITDA
‪3.85‬
Profitability
Profit Margin
‪33.35%‬
Operating Margin
‪70.15%‬
Return on Assets
‪47.02%‬
Return on Equity
‪-9.17%‬
Ownership
Shares Outstanding
165.23M
Float
136.75M
Short % of Shares Outstanding
‪12.38%‬
Held by Insiders
‪3.23%‬
Held by Institutions
‪98.87%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪4.15‬
200-Day Avg
‪4.00‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Average price target
‪$ 6.10‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IRWD - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Peers - IRWD - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NASDAQ.
- IRWDNASDAQIronwood Pharmaceuticals, Inc. Class A Common Stock619.64MMarket Cap+57.87%52-week change4.78P/E (Trailing)‪33.35%‬Profit Margin
- NBIXNASDAQNeurocrine Biosciences, Inc.14.55BMarket Cap+2.62%52-week change20.93P/E (Trailing)‪20.91%‬Profit Margin
- AMRXNASDAQAmneal Pharmaceuticals, Inc.7.07BMarket Cap+48.03%52-week change42.29P/E (Trailing)‪5.04%‬Profit Margin
- ALKSNASDAQAlkermes plc7.00BMarket Cap+25.77%52-week change109.87P/E (Trailing)‪3.96%‬Profit Margin
- LNTHNASDAQLantheus Holdings Inc.6.52BMarket Cap+47.28%52-week change23.91P/E (Trailing)‪17.69%‬Profit Margin
- KNSANASDAQKiniksa Pharmaceuticals International, plc Class A Ordinary Shares5.83BMarket Cap+49.48%52-week change76.56P/E (Trailing)‪9.59%‬Profit Margin
- DIODNASDAQDiodes Incorporated4.43BMarket Cap+49.74%52-week change57.61P/E (Trailing)‪5.26%‬Profit Margin
Profile Summary - IRWD - Ironwood Pharmaceuticals, Inc. Class A Common Stock
About
Ironwood Pharmaceuticals, Inc. Class A Common Stock represents ownership in Ironwood Pharmaceuticals, Inc., a biotechnology company focused on developing and commercializing therapies for gastrointestinal disorders and rare diseases. Its current business centers on human therapeutics, with an emphasis on medicines for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
